IRIS UniCatt

Ruggeri, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.805
EU - Europa 3.385
AS - Asia 2.147
SA - Sud America 437
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 61
OC - Oceania 11
AN - Antartide 1
Totale 9.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.708
IT - Italia 1.314
SG - Singapore 958
DE - Germania 650
CN - Cina 541
BR - Brasile 350
SE - Svezia 335
UA - Ucraina 269
FR - Francia 238
VN - Vietnam 208
GB - Regno Unito 131
IE - Irlanda 117
IN - India 81
ID - Indonesia 79
FI - Finlandia 70
RU - Federazione Russa 60
TR - Turchia 56
CA - Canada 50
BD - Bangladesh 37
HK - Hong Kong 35
ES - Italia 34
NL - Olanda 33
AR - Argentina 27
BE - Belgio 26
CH - Svizzera 24
JP - Giappone 21
PL - Polonia 20
IR - Iran 18
ZA - Sudafrica 18
EC - Ecuador 17
IQ - Iraq 17
MX - Messico 16
AT - Austria 15
PK - Pakistan 15
VE - Venezuela 15
CO - Colombia 12
KR - Corea 11
TN - Tunisia 10
ET - Etiopia 8
PH - Filippine 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AU - Australia 7
JO - Giordania 7
KZ - Kazakistan 7
RO - Romania 7
HN - Honduras 6
KE - Kenya 6
MA - Marocco 6
CL - Cile 5
CR - Costa Rica 5
EU - Europa 5
GR - Grecia 5
HR - Croazia 5
MY - Malesia 5
PT - Portogallo 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EG - Egitto 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SV - El Salvador 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
MZ - Mozambico 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AQ - Antartide 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LR - Liberia 1
ME - Montenegro 1
Totale 9.844
Salva come PNG Salva come JPEG
Città #
Chandler 434
Singapore 412
Ashburn 290
San Jose 256
Jacksonville 190
Milan 184
Ann Arbor 147
Plan 117
Dublin 115
Beijing 114
San Mateo 112
Cattolica 110
Rome 93
Nanjing 92
Woodbridge 76
Ho Chi Minh City 73
Jakarta 69
Wilmington 68
Bremen 67
Boston 62
Lauterbourg 61
Dearborn 59
Los Angeles 59
Munich 59
Lawrence 57
New York 53
Mountain View 46
Hanoi 44
Nanchang 42
Marseille 41
Seattle 41
Buffalo 40
São Paulo 39
Moscow 37
Hong Kong 32
Houston 31
Redwood City 27
Turin 27
Frankfurt am Main 26
Frattamaggiore 26
Izmir 25
Shanghai 25
Brussels 23
Paris 21
Chicago 20
Boardman 19
Bari 18
Jiaxing 17
Lancaster 17
Redmond 17
Enterprise 16
Hebei 16
Tokyo 16
Bologna 15
Kunming 15
Fairfield 14
Hangzhou 14
Orem 14
Brooklyn 13
Changsha 13
Dallas 13
Norwalk 13
Nürnberg 13
Atlanta 12
Augusta 12
Da Nang 12
Detroit 12
Hefei 12
Santa Clara 12
Torino 12
University Park 12
Chennai 11
Guangzhou 11
Montreal 11
Falls Church 10
Fremont 10
Princeton 10
San Francisco 10
Brasília 9
Como 9
Kish 9
Kraków 9
London 9
Mumbai 9
Napoli 9
Ottawa 9
Pune 9
Rio de Janeiro 9
Tianjin 9
Denver 8
Düsseldorf 8
Johannesburg 8
Taranto 8
Toronto 8
Warsaw 8
Zurich 8
Addis Ababa 7
Amman 7
Curitiba 7
Dhaka 7
Totale 4.667
Salva come PNG Salva come JPEG
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 840
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 411
Between rationing and rationalization. The challenges of the Italian National Health Service during the age of the great crisis 330
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 234
Economia sanitaria 231
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 205
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 196
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 192
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 191
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 177
Healthcare expenditure on prevention in the spending review era 174
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 168
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 168
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 168
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 165
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 161
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 154
Cost effectiveness analysis of transnasal fentalyl citrate in the treatment of BTcP 152
A cost effectiveness analysis of cataract surgery 152
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 147
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study. 147
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 146
Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis 144
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 141
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 139
Economic evaluation of screening programs for HCV: evidence from literature. 138
Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort 134
Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults 132
Do Probability and Certainty Equivalent techniques lead to inconsistent results? Evidence from gambles involving life years and quality of life. 131
Valutazione economica di Teysuno nel trattamento del Carcinoma gastrico avanzato 130
A new decision model for economic evaluation of novel therapies for HCV 129
The cost-effectiveness of alternative strategies against HBV in Italy 128
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 127
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. 126
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 123
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. 123
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 123
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 122
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 120
New Healthcare Professional Roles in Europe: a Survey of Patients' Experiences and Views in Nine Countries 119
New professional roles and patient satisfaction: evidence from a European survey along three clinical pathways 119
The minimum clinically important difference of the EQ-5D index. 117
Valutazione economica di ranibizumab vs pegaptanib o vs terapia fotodinamica con verteporfina 116
Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone. 116
Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. 116
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 115
Valutazione economica della tossina botulinica per la profilassi dell’emicrania cronica 114
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 111
Economic Assessment of an Anti-HCV Screening Program in Italy 107
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 107
Normative needs in healthcare: toward a new conceptualization of equity and capabilities. 105
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 104
Setting research priorities in the feld of emergency management: which piece of information are you willing to pay more? 104
Cost effectiveness studies in HIV treatment with Lopinavir/Ritonavir: a Review. 100
Introduction to essay health and economics 100
Economic assessment of Eltrombopag in the treatment of thrombocytopenia 99
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy . 99
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 98
Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. 93
Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study. 93
Analisi economica per l’estensione della vaccinazione contro l’influenza agli individui di età 50-64: risparmi sociali e analisi di Budget Impact 91
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. 91
The cost effectiveness of Botox in Italian patients with chronic migraine. 91
Valutazione dei costi delle infezioni nosocomiali da E.Coli in un policlinico romano di 1700 posti letto 86
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review 77
Is risk attitude really specific within the health context domain? Further evidence from an Italian survey using Probability Equivalent technique and face to face interviews 74
Is risk outcome specific within the health domain? 70
Totale 9.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022551 0 0 20 27 31 26 54 108 30 43 84 128
2022/20231.319 147 186 96 223 91 170 56 113 163 17 46 11
2023/2024614 36 179 20 38 32 67 20 29 18 26 83 66
2024/20251.061 24 50 105 28 121 29 13 46 207 87 177 174
2025/20262.515 435 85 100 202 420 151 474 162 142 215 82 47
2026/2027536 99 351 86 0 0 0 0 0 0 0 0 0
Totale 9.951